Your browser doesn't support javascript.
loading
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
Marconi, Silvia; Croce, Michela; Chiorino, Giovanna; Rossi, Giovanni; Guana, Francesca; Profumo, Aldo; Ostano, Paola; Alama, Angela; Longo, Luca; De Luca, Giuseppa; Dono, Mariella; Dal Bello, Maria Giovanna; Ponassi, Marco; Rosano, Camillo; Romano, Paolo; Cavalieri, Zita; Grassi, Massimiliano; Tagliamento, Marco; Zullo, Lodovica; Venturi, Consuelo; Dellepiane, Chiara; Mastracci, Luca; Bennicelli, Elisa; Pronzato, Paolo; Genova, Carlo; Coco, Simona.
Afiliación
  • Marconi S; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Croce M; Biotherapies Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Chiorino G; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, 13900 Biella, Italy.
  • Rossi G; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Guana F; Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.
  • Profumo A; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, 13900 Biella, Italy.
  • Ostano P; Proteomics and Mass Spectrometry Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Alama A; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, 13900 Biella, Italy.
  • Longo L; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • De Luca G; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Dono M; Molecular Diagnostic Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Dal Bello MG; Molecular Diagnostic Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Ponassi M; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Rosano C; Proteomics and Mass Spectrometry Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Romano P; Proteomics and Mass Spectrometry Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Cavalieri Z; Proteomics and Mass Spectrometry Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Grassi M; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Tagliamento M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Zullo L; Department of Internal Medicine and Medical Specialties, University of Genova, 16132 Genova, Italy.
  • Venturi C; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Dellepiane C; Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Mastracci L; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Bennicelli E; Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Pronzato P; Department of Surgical Sciences and Integrated Diagnostic, University of Genova, 16132 Genova, Italy.
  • Genova C; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Coco S; Medical Oncology 2 Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Cancers (Basel) ; 14(14)2022 Jul 14.
Article en En | MEDLINE | ID: mdl-35884472

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia